Ziihera

Active Ingredient(s): Zanidatamab-hrii
FDA Approved: * November 20, 2024
Pharm Company: * JAZZ PHARMS
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ziihera 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 68727-950
Labeler:
Jazz Pharmaceuticals, Inc.